60
Participants
Start Date
May 3, 2017
Primary Completion Date
November 30, 2020
Study Completion Date
February 1, 2022
Rivaroxaban
Rivaroxaban 15 or 20mg tablet by mouth, every 24 hours, continuous use.
Dabigatran and Apixaban
Dabigatrana 110 or 150 mg tablet and Apixaban 2,5 or 5mg tablet by mouth, every 12 hours, continuous use.
Warfarin
The dosage of Warfarin is individualized for each patient, according to the patient's TP/INR value. The value of TP/INR should be in the therapeutic dosage of 2.0 to 3.0
Heart Institute of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo
University of Sao Paulo General Hospital
OTHER